Hope for Alzheimer's blood tests on the NHS within five years
Thursday, 9 November 2023 Blood tests which help detect Alzheimer's could be made available on the NHS within five years as charities join forces for a £5m project.
Labour Leader Sir Keir Starmer pledges to cut NHS waiting lists during a speech in the Midlands. Speaking at a Q & A with shadow health secretary Wes Streeting, Starmer told the audience, “we’ve done it before, we can do it again.”
Report by Ajagbef. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Labour will pledge to clear the backlog of patients waiting more than 18 weeks for NHS treatment within five years of government if the party gets into power. Sky News
An escalation process that allows patients to demand a second opinion if they think their condition, or that of a loved one, is deteriorating but their concerns.. Sky News
Sir Keir Starmer has promised an extra 40,000 NHS appointments per week in a bid to reduce waiting lists. The Labour party leader pledged to make healthcare a priority if his party gets into power in July. "That will make a massive difference to the lives of people and not just to their physical health," he added.
Report by Kennedyl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Newly-Discovered Gene Variant , Could Help Prevent or Treat , Alzheimer's Disease.
'Newsweek' reports that scientists have uncovered
a genetic variant that has the potential to reduce
the odds of developing Alzheimer's by as much as 70%.
The discovery could reportedly lead to new methods to
effectively treat or prevent the disease which impacts
approximately 5.8 million people in the United States alone.
Some genetic variants have been found to have an
association with an increased likelihood of developing
the disease, while other variants offer protection. .
A team from Columbia University found that
genes involved with the production of fibronectin
play a crucial role in developing Alzheimer's.
Healthy individuals usually only have fibronectin present
in small amounts along their blood-brain barrier, while
those with Alzheimer's have much higher quantities.
It's a classic case of too much
of a good thing. It made us think
that excess fibronectin could be
preventing the clearance of [abnormal
protein clumps] from the brain, Caghan Kizil, co-leader of the study and professor of
neurological sciences at Columbia University's Vagelos
College of Physicians and Surgeons, via 'Newsweek'.
The team believes that methods aimed at reducing
fibronectin could play a crucial role in developing
new treatments and preventative measures. .
Anything that reduces excess
fibronectin should provide some
protection, and a drug that does
this could be a significant step
forward in the fight against
this debilitating condition, Caghan Kizil, co-leader of the study and professor of
neurological sciences at Columbia University's Vagelos
College of Physicians and Surgeons, via 'Newsweek'.
Our findings suggest that...
we may be able to develop new
types of therapies that mimic
the gene's protective effect
to prevent or treat the disease, Caghan Kizil, co-leader of the study and professor of
neurological sciences at Columbia University's Vagelos
College of Physicians and Surgeons, via 'Newsweek'.
The Columbia University team's
findings were published in the
journal 'Acta Neuropathologica.'
Credit: Wibbitz Top Stories Duration: 01:31Published